Soluble TNF receptors and their use in treatment of disease
Details for Australian Patent Application No. 2007309650 (hide)
International Classifications
Event Publications
18 June 2009 PCT application entered the National Phase
PCT publication WO2008/051306 Priority application(s): WO2008/051306
26 November 2009 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Ercole Biotech, Inc. and The University of North Carolina at Chapel Hill, Application No. 2007309650, correct INID (31) PCT/US2006/004365; INID 08.02.06; INID US; to read INID (31) PCT/ US2006/043651; INID 10.11.06; INID (31) US.
4 February 2010 Amendment Made
The nature of the amendment is: Add the name of the co-inventor Orum, Henrik
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser